Stratos Wealth Partners’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
Other funds holding ANAB
FM
CAM
O
PHS
Stratos Wealth Partners's ANAB Position: Q3 2018 in Review
Stratos Wealth Partners sold out of AnaptysBio (ANAB) in Q3 2018, closing a stake of 3,607 shares — an estimated $256K sold.
Stratos Wealth Partners first reported a position in ANAB in Q4 2017 and held it in 3 quarters. The position peaked at $375K in Q1 2018. 129 funds tracked by Wall St. Rank hold ANAB as of Q3 2018.
- Stratos Wealth Partners reported no remaining AnaptysBio position as of Q3 2018 after selling out during the quarter.
- Stratos Wealth Partners sold 3,607 AnaptysBio shares in Q3 2018, an estimated $256K.
- Stratos Wealth Partners first reported a position in AnaptysBio in Q4 2017 and held it in 3 quarters.
- Stratos Wealth Partners's AnaptysBio position peaked at $375K in Q1 2018.
- 129 funds tracked by Wall St. Rank held AnaptysBio as of Q3 2018.
Based on Stratos Wealth Partners's 13F filing for Q3 2018, filed 2 Nov 2018.